暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股期權個股詳情
CGEM240517C30000
- 0.05
- -0.67-93.06%
延時15分鐘行情收盤價 05/17 15:54 (美東)
0.05最高價0.05最低價
0.05今開0.72昨收4張成交量159張未平倉合約數30.00行權價20.00成交額1766.13%引伸波幅29.69%溢價2024/05/17到期日0.00内在价值100合約乘數-1天距到期日0.05時間價值100合約規模美式期權類型0.0397Delta0.0261Gamma463.40槓桿倍數-5.6308Theta0.0000Rho18.42有效槓桿0.0002Vega
分時
- 5日
- 日K
新聞
快訊 | Cullinan Therapeutics申請出售股東轉售多達1440萬股股票
快訊 | Cullinan Therapeutics Inc申請出售股東轉售多達1440萬股股票——美國證券交易委員會備案
快訊 | 在Cullinan Therapeutics公佈第一季度業績並提供公司最新情況後，該公司股價走低
HC Wainwright將庫裏南腫瘤學的目標股價從29美元調整至28美元，維持買入評級
Capital IQ調查的分析師表示，庫裏南腫瘤學（CGEM）的平均買入評級，目標股價區間爲28美元至40美元。價格：25.23，漲幅：-1.49，變動百分比：-5.58
HC Wainwright & Co. 維持庫裏南腫瘤學的買入價格。
HC Wainwright & Co. 維持庫裏南腫瘤學的買入價格。
快訊 | Wedbush重申Cullinan Therapeutics的跑贏大盤，維持36美元的目標股價
評論
$Cullinan Therapeutics(CGEM.US$
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
Gainers:
• $Cullinan Therapeutics(CGEM.US$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors(RIDE.US$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin(APP.US$ +15.5%(In reaction to earnings)
• $SmartRent(SMRT.US$ +15.4%(In reaction to earnings)
• $Coupang(CPNG.US$ +14.3%(In reaction to earn...
• $Cullinan Therapeutics(CGEM.US$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors(RIDE.US$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin(APP.US$ +15.5%(In reaction to earnings)
• $SmartRent(SMRT.US$ +15.4%(In reaction to earnings)
• $Coupang(CPNG.US$ +14.3%(In reaction to earn...
12
3
閱讀更多